Tag: Compliance issues
Trump’s Anti-Bribery Law Pause: Impact on Pharma Behavior
Between 2011 and 2020, the world witnessed a staggering $1.34 billion in fines paid by the top pharmaceutical companies to the U.S. government for...
BREAKING NEWS
Trump’s Anti-Bribery Law Pause: Impact on Pharma Behavior
Between 2011 and 2020, the world witnessed a staggering $1.34 billion in fines paid by the top pharmaceutical companies to the U.S. government for...
